The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Showing 1-12 of 12 articles
Sirolimus-eluting stents with ultrathin struts versus everolimus-eluting stents for patients undergoing percutaneous coronary intervention: final three-year results of the TALENT trial
de Winter R,
Zaman A,
Hara H,
Gao C,
Ono M,
Garg S,
Smits P,
Tonino P,
Hofma S,
Moreno R,
Choudhury A,
Petrov I,
Cequier A,
Colombo A,
Kaul U,
Onuma Y,
Serruys P
August 19, 2022 | 10.4244/EIJ-D-21-00766
Long-term clinical outcomes of everolimus-eluting bioresorbable scaffolds versus everolimus-eluting stents: final five-year results of the AIDA randomised clinical trial
Kerkmeijer L,
Renkens M,
Tijssen R,
Hofma S,
van der Schaaf R,
Arkenbout EK,
Weevers A,
Garcia-Garcia H,
Kraak R,
Piek JJ,
Tijssen J,
Henriques J,
de Winter R,
Wykrzykowska JJ
March 18, 2022 | 10.4244/EIJ-D-21-00419
Outcomes of bioresorbable vascular scaffolds versus everolimus-eluting stents by coronary complexity: a sub-analysis of the AIDA trial
Kraak R,
Tijssen R,
van Dongen I,
Elias J,
Hofma S,
van der Schaaf R,
Arkenbout EK,
Weevers A,
Tijssen J,
Piek JJ,
de Winter R,
Henriques J,
Wykrzykowska JJ
December 4, 2020 | 10.4244/EIJ-D-18-00884
Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent in routine PCI: three-year clinical outcomes from the AIDA trial
Kerkmeijer L,
Tijssen R,
Hofma S,
van der Schaaf R,
Arkenbout K,
Kraak R,
Weevers A,
Piek JJ,
de Winter R,
Tijssen J,
Henriques J,
Wykrzykowska JJ,
Ijsselmuiden A,
Kauer F,
Beijk M,
Vis M,
Koch K
September 20, 2019 | 10.4244/EIJ-D-19-00325
Three-year follow-up of the randomised comparison between an everolimus-eluting bioresorbable scaffold and a durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction (TROFI II trial)
Katagiri Y,
Onuma Y,
Asano T,
Iñiguez A,
Jensen L,
Cequier A,
Hofma S,
Christiansen E,
Suttorp M,
Brugaletta S,
Räber L,
Sabaté M,
Windecker S,
Serruys P,
Räber L,
Sabaté M,
Serruys P
December 7, 2018 | 10.4244/EIJ-D-18-00839
Complete two-year follow-up with formal non-inferiority testing on primary outcomes of the AIDA trial comparing the Absorb bioresorbable scaffold with the XIENCE drug-eluting metallic stent in routine PCI
Tijssen R,
Kraak R,
Hofma S,
van der Schaaf R,
Arkenbout EK,
Weevers A,
Elias J,
van Dongen I,
Koch K,
Baan Jr J,
Vis M,
de Winter R,
Piek JJ,
Tijssen J,
Henriques J,
Wykrzykowska JJ
July 20, 2018 | 10.4244/EIJ-D-18-00335
Evaluation of vascular healing of polymer-free sirolimus-eluting stents in native coronary artery stenosis: a serial follow-up at three and six months with optical coherence tomography imaging
Suwannasom P,
Onuma Y,
Benit E,
Gach O,
von Birgelen C,
Hofma S,
Sotomi Y,
Bo X,
Zhang Y-J,
Gao R,
Garcia-Garcia H,
Wykrzykowska JJ,
de Winter R,
Serruys P
August 5, 2016 | 10.4244/EIJV12I5A97
Arterial healing following primary PCI using the Absorb everolimus-eluting bioresorbable vascular scaffold (Absorb BVS) versus the durable polymer everolimus-eluting metallic stent (XIENCE) in patients with acute ST-elevation myocardial infarction: rationale and design of the randomised TROFI II study
Räber L,
Onuma Y,
Brugaletta S,
Garcia-Garcia H,
Backx B,
Iñiguez A,
Jensen L,
Cequier-Fillat A,
Pilgrim T,
Christiansen E,
Hofma S,
Suttorp M,
Serruys P,
Sabaté M,
Windecker S
July 20, 2016 | 10.4244/EIJY15M08_03
Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with coronary artery disease: three-year follow-up of the COMPARE II (Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent) trial
Vlachojannis G,
Smits P,
Hofma S,
Togni M,
Vázquez N,
Valdes M,
Voudris V,
Puricel S,
Slagboom T,
Goy J-J,
den Heijer P,
van der Ent M
July 20, 2015 | 10.4244/EIJV11I3A53
Latest news
AHEAD OF PRINT
COMBINE OCT–FFR study extended follow-up
FREE ARTICLE - Enrico Fabris et al
September 28, 2022
NEW ISSUE
A state-of-the-art on CTO recanalisation; timing of coronary angiography in NSTE-ACS; an expert consensus on the use of IVUS in peripheral interventions, and more
September 20, 2022
AHEAD OF PRINT
The UZ Clear study
FREE ARTICLE - Bert Vandeloo et al
September 23, 2022
AHEAD OF PRINT
Subanalysis of SCOPE 2 – pacemaker and LBBB
FREE ARTICLE - Costanza Pellegrini et al
September 21, 2022
AHEAD OF PRINT TCT
Early Alirocumab treatment in STEMI
FREE ARTICLE - Shamir R. Mehta et al
September 19, 2022
AHEAD OF PRINT TCT
Timing of Bioprosthetic valve fracture in transcatheter valvein- valve intervention: impact on valve durability and leaflet integrity
FREE ARTICLE - David Meier et al
September 18, 2022
AHEAD OF PRINT TCT
Acute Outcomes for the Full US Cohort of the FLASH Mechanical Thrombectomy Registry in Pulmonary Embolism
FREE ARTICLE - Catalin Toma et al
September 18, 2022